Literature DB >> 28314237

Non-autonomous cell proliferation in the mammary gland and cancer.

Robert J Weber1, Tejal A Desai2, Zev J Gartner3.   

Abstract

Cells decide whether to grow and divide by integrating internal and external signals. Non-autonomous cell growth and proliferation occurs when microenvironmental signals from neighboring cells, both physical and secreted, license this decision. Understanding these processes is vital to developing an accurate framework for cell-cell interactions and cellular decision-making, and is useful for advancing new therapeutic strategies to prevent dysregulated growth. Here, we review some recent examples of non-autonomous cell growth in the mammary gland and tumor cell proliferation.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28314237      PMCID: PMC8811621          DOI: 10.1016/j.ceb.2017.02.009

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  70 in total

Review 1.  On hormone action in the mammary gland.

Authors:  J M Rosen
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

Review 2.  Tumors as organs: complex tissues that interface with the entire organism.

Authors:  Mikala Egeblad; Elizabeth S Nakasone; Zena Werb
Journal:  Dev Cell       Date:  2010-06-15       Impact factor: 12.270

Review 3.  ERrrr…where are the progenitors? Hormone receptors and mammary cell heterogeneity.

Authors:  Giusy Tornillo; Matthew J Smalley
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-07-21       Impact factor: 2.673

4.  Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function.

Authors:  Adam C Pond; Xue Bin; Torey Batts; Kevin Roarty; Susan Hilsenbeck; Jeffrey M Rosen
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

5.  Progesterone/RANKL is a major regulatory axis in the human breast.

Authors:  Tamara Tanos; George Sflomos; Pablo C Echeverria; Ayyakkannu Ayyanan; Maria Gutierrez; Jean-Francois Delaloye; Wassim Raffoul; Maryse Fiche; William Dougall; Pascal Schneider; Ozden Yalcin-Ozuysal; Cathrin Brisken
Journal:  Sci Transl Med       Date:  2013-04-24       Impact factor: 17.956

Review 6.  American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Authors:  M Elizabeth H Hammond; Daniel F Hayes; Mitch Dowsett; D Craig Allred; Karen L Hagerty; Sunil Badve; Patrick L Fitzgibbons; Glenn Francis; Neil S Goldstein; Malcolm Hayes; David G Hicks; Susan Lester; Richard Love; Pamela B Mangu; Lisa McShane; Keith Miller; C Kent Osborne; Soonmyung Paik; Jane Perlmutter; Anthony Rhodes; Hironobu Sasano; Jared N Schwartz; Fred C G Sweep; Sheila Taube; Emina Emilia Torlakovic; Paul Valenstein; Giuseppe Viale; Daniel Visscher; Thomas Wheeler; R Bruce Williams; James L Wittliff; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2010-04-19       Impact factor: 44.544

Review 7.  A minimal fate-selection switch.

Authors:  Leor S Weinberger
Journal:  Curr Opin Cell Biol       Date:  2015-11-21       Impact factor: 8.382

Review 8.  Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.

Authors:  Aleksander Skardal; Thomas Shupe; Anthony Atala
Journal:  Drug Discov Today       Date:  2016-07-12       Impact factor: 8.369

9.  Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium.

Authors:  Gerard A Tarulli; Duvini De Silva; Victor Ho; Kamini Kunasegaran; Kakaly Ghosh; Bryan C Tan; Dmitry V Bulavin; Alexandra M Pietersen
Journal:  Breast Cancer Res       Date:  2013-01-31       Impact factor: 6.466

Review 10.  Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment.

Authors:  Xiao-xiao Sun; Qiang Yu
Journal:  Acta Pharmacol Sin       Date:  2015-09-21       Impact factor: 6.150

View more
  4 in total

1.  Unraveling cell-to-cell signaling networks with chemical biology.

Authors:  Zev J Gartner; Jennifer A Prescher; Luke D Lavis
Journal:  Nat Chem Biol       Date:  2017-05-17       Impact factor: 15.040

2.  The acid-base transport proteins NHE1 and NBCn1 regulate cell cycle progression in human breast cancer cells.

Authors:  Mette Flinck; Signe Hoejland Kramer; Julie Schnipper; Anne Poder Andersen; Stine Falsig Pedersen
Journal:  Cell Cycle       Date:  2018-07-13       Impact factor: 4.534

Review 3.  Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.

Authors:  Xixi Dou; Pingzhen Tong; Hai Huang; Lucas Zellmer; Yan He; Qingwen Jia; Daizhou Zhang; Jiang Peng; Chenguang Wang; Ningzhi Xu; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

Review 4.  Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast.

Authors:  Jessica S Helm; Ruthann A Rudel
Journal:  Arch Toxicol       Date:  2020-05-13       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.